Complexo Hospitalario Universitario de Santiago
Centro asistencial
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (82)
2024
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders
Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
Methylomic signature of current cannabis use in two first-episode psychosis cohorts
Molecular Psychiatry
-
Oral anticoagulants: A plausible new treatment for Alzheimer's disease?
British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776
-
Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders
Genetics in Medicine, Vol. 26, Núm. 4
2023
-
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
International Journal of Cancer, Vol. 153, Núm. 9, pp. 1579-1591
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384
-
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160
-
Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials
The American journal of cardiology, Vol. 205, pp. 321-324
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
Radiotherapy and Oncology, Vol. 187
-
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
The Lancet Rheumatology, Vol. 5, Núm. 4, pp. e184-e199
-
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
JNCI Cancer Spectrum, Vol. 7, Núm. 6
-
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
The Lancet Oncology, Vol. 24, Núm. 12, pp. 1399-1410
-
Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation
British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478
-
Reply to: Comments on “(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer”
International Journal of Cancer
-
Survival after Invasive or Conservative Management of Stable Coronary Disease
Circulation, Vol. 147, Núm. 1, pp. 8-19
-
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978
-
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events
Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611